Top Markets
Coin of the day
Kringle Pharma, Inc. Kringle Pharma, Inc.

Kringle Pharma, Inc.

4884
Rank in Stocks #29210
Kringle Pharma, Inc. specializes in the innovation, production, and... Kringle Pharma, Inc. specializes in the innovation, production, and distribution of hepatocyte growth factor (HGF) protein-based therapeutics aimed at regenerative medicine. The company's cutting-edge HGF solutions are designed to address serious medical conditions including acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scars, and acute kidney injury. Founded in 2001, Kringle Pharma operates from its base in Ibaraki, Japan.
Share Price
$2.77
Market Cap
$22.40M
Change (1 day)
-0.93%
Change (1 year)
-17.48%
Country
JP
Trade Kringle Pharma, Inc. (4884)

Category

Price of 4884 with the market cap of B
Kringle Pharma, Inc. Kringle Pharma, Inc.
4884
$2.77
Market Capitalization of Kringle Pharma, Inc.(4884)
Market Cap: $22.40M
As of August 2026 Kringle Pharma, Inc. has a market cap of $22.40M. This makes Kringle Pharma, Inc. the world's 29210th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Kringle Pharma, Inc. from 2020 to 2026
4884 compared with Top 5 Most Popular stocks
Price of 4884 Asset B Mkt. of B Results
Kringle Pharma, Inc. Kringle Pharma, Inc.
$660,019 $22.40M
$5.332T +23,802,760.56%
Kringle Pharma, Inc. Kringle Pharma, Inc.
$564,747 $22.40M
$4.562T +20,366,885.24%
Kringle Pharma, Inc. Kringle Pharma, Inc.
$512,117 $22.40M
$4.137T +18,468,812.00%
Kringle Pharma, Inc. Kringle Pharma, Inc.
$443,317 $22.40M
$3.581T +15,987,621.99%
Kringle Pharma, Inc. Kringle Pharma, Inc.
$345,270 $22.40M
$2.789T +12,451,694.24%